Associate Laboratory

In 2001 ITQB was awarded the status of Laboratório Associado by the Ministry of Science & Technology.  Under this status, a programme was established in a partnership between ITQB, the Instituto Gulbenkian de Ciência (IGC) and the Instituto de Biologia Experimental e Tecnológica (IBET), bringing together a number of different expertises that effectively combine scientific discoveries with potential applications.

The Associate Laboratory constitutes an excellent Science cluster for areas such as life sciences, health and biotechnology.

Director: José Artur Martinho Simões (ITQB Director)

600 Researchers (265 PhD holders)

6 Biotechnology Companies

19 Active Patents

1273 Publications in ISI Journals (2001-2006)

ITQB

ITQB belongs to the Universidade Nova de Lisboa and is devoted to advanced training and research in the areas of Biology and Chemistry and associated Technologies. It is an open institution, with a small number of paid staff and the majority of researchers belonging to other institutions or being financed by grants. The research at ITQB covers a vast interdisciplinary area with an emphasis in Chemistry and Biology. 

IGC

Supported by the Calouste Gulbenkian Foundation, IGC 's activities are focused on biomedical research, particularly those related to the genetic basis of development and evolution of complexe systems, namely, Developmental Biology and Evolution, Genetic Susceptibility of Complex Diseases (diabetes, lupus and autism) and Infections, Molecular and Cellular Mechanisms of Response to Stress, Control of Cellular Cycle and Genetic Expression, Immunity Tolerance and the development of new Strategic Vaccines.

Go to IGC

IBET

Situated in the same building of ITQB, IBET is a private non-profit organisation. It is a platform for University-Industry collaboration in the area of Biotechnology. Its pilot plant infra-structure is certified as "current Good Manufacturing Practices" and three of its services are certified "Good Laboratory Practices". These constitute a unique group at the national level. IBET has a long track-record of collaborative Research and Development in areas such as Biopharmaceutical Products, Vaccine Development, Medical and Veterinarian Diagnosis, Production of purified protein for research of Structure-Function relationships, Starter Cultures of Micro-organisms, and Supercritical Fluid Extraction. IBET also has an important role as a base for start-up companies.

Go to IBET